TIGR (.053/.054) News just out!
About to run!!
International Investment Firm Acquires Stake in Tiger Telematics
Tuesday December 24, 10:07 am ET


JACKSONVILLE, Fla., Dec. 24 /PRNewswire-FirstCall/ -- Tiger Telematics, Inc. (OTC Bulletin Board: TIGR - News; www.tigertelematics.com ) headquartered here and with offices in London, UK, said it has been informed by Messer AJ Nassar (Nassar), former Chairman and CEO, that in a private transaction, he has sold 8.9 million shares of TIGR common stock to a private investment group, Juanita Development Group ("Juanita").
ADVERTISEMENT


John Clark, Managing Director for Juanita commented, "Juanita Development Group focuses its investment activities on emerging growth ventures by providing investment capital and assisting with the execution of business plans and partnering strategies. Our strategy of focusing on long term growth and developing innovative and proprietary ideas fits nicely with the direction of Tiger Telematics. The successful deployment of the proprietary Location Technology by Tiger Telematics, through a number of business applications and the management team's continued focus on developing true-to-life business applications that create accretive earnings opportunities and enhanced shareholder value make this a very exciting investment opportunity for Jaunita."

Tiger Telematics, Inc also reported in its recent SEC filing that, effective October 17, 2002 it reached an agreement with Messer Nassar and Messer Edward Kenny, former Director of the company, to convert a combined total of four hundred and fifty five thousand ($455,000.00) in Promissory Notes and debt owed by the company into restricted common stock. The common stock, converted at $0.10 per share, carry the restrictions under Rule 144 of the Securities act of 1933. "This transaction was completed to improve the balance sheet and liquidity position of Tiger," advised Michael Carrender, Chief Executive Officer of Tiger Telematics, Inc.

About Tiger

Tiger Telematics, Inc. is a designer, developer and marketer of mobile telematic systems and services that combine global positioning and voice recognition technology to locate and track vehicles and people down to street level in countries throughout the world. The systems are designed to operate on GSM, which is the standard operating system for wireless carriers in the UK and in Continental Europe, and are currently being marketed to GSM current and potential subscribers, primarily by the company's London-based subsidiary, Tiger Telematics Ltd.

Except for historical matters contained herein, the matters discussed in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that these forward-looking statements reflect numerous assumptions and involve risks and uncertainties that may affect Tiger Telematics, Inc. and its subsidiary businesses and prospects and cause actual results to differ materially from these forward-looking statements. Among the factors that could cause actual results to differ are Tiger Telematics, Inc.'s operating history; competition; low barriers to entry; reliance on strategic relationships; rapid technological changes; inability to complete transactions on favorable terms; and those risks discussed in the Company's filings with the SEC.

For further information please contact: Mike Carrender, CEO of Tiger Telematics, Inc., +1-904-279-9240.


"Using no way as way -
Having no limitation as limitation"

VLTS important news today:
Valentis and Schering A.G. Enter Multi-Product Collaboration
Friday December 20, 1:00 am ET


BURLINGAME, Calif., Dec. 20 /PRNewswire-FirstCall/ -- Valentis, Inc. (Nasdaq: VLTS - News) and Schering AG, Germany (NYSE: SHR; FSE: SCH), announced today that they have signed a multi-product license and option agreement to develop and commercialize gene-based therapeutic products. Under terms of the agreement Schering will obtain exclusive, world-wide rights to Valentis' PINC(TM) polymer based synthetic gene delivery and the GeneSwitch® gene regulation technologies for use with up to two genes proprietary to Schering, and an option for non-exclusive rights to the PINC technology for a third gene. Schering will make an initial payment of $1.1 million in cash to Valentis in license and option fees. Additional financial details were not disclosed.

"Using no way as way -
Having no limitation as limitation"

Welcome back ukie!
You're just in time for the end of the year run!

"Using no way as way -
Having no limitation as limitation"

I see now -
BB already reported it. (GBLXQ) I made a penny on it!

"Using no way as way -
Having no limitation as limitation"

GBLXQ?
It's already had its run, I know, but it was fast and furious.

"Using no way as way -
Having no limitation as limitation"

OT - did anyone get ETRADE premiums?
They were supposed to send out a Rolling Stones briefcase to their quality customers. PM me if you got one! low


"Using no way as way -
Having no limitation as limitation"

OT - did anyone get ETRADE premiums?
They were supposed to send out a Rolling Stones briefcase to their quality customers. PM me if you got one! low

"Using no way as way -
Having no limitation as limitation"

It looks like a good move for you, bb!
I hope that it runs to a dollar for you!! (ADOT)

"Using no way as way -
Having no limitation as limitation"

ADOT is definitely a momo.
Past history indicates that the upward movement will be stopped cold by those who bought lower and will be selling for a 50% (or so) gain.
It could be different this time, but it would have to go up to .0025 to make any real money (no way I'm sinking a wad into this one!) and I'll just watch from afar.

"Using no way as way -
Having no limitation as limitation"

Keep an eye on SURE/IPXL/NETE
Generic Claritin and Claritin OTC (tomorrow) hit the shelves this month (IPXL).

"The Tier 1 Products are: Loratadine/Pseudoephedrine Sulfate 12 hour Extended Release Tablets (generic of Claritin® D 12-Hour), Loratadine/Pseudoephedrine Sulfate 24 hour Extended Release Tablets (generic of Claritin® D 24-Hour), Loratadine Orally Disintegrating Tablets (generic of Claritin® Reditabs), Bupropion Extended Release Tablets (generic of Wellbutrin® SR Tablets), Bupropion Extended Release Tablets (generic of Zyban® Tablets) and Omeprazole Delayed Release Capsules (generic of Prilosec® Capsules)."


"Using no way as way -
Having no limitation as limitation"

NETE with good news today
Alliance with Amazon. No real volume yet.

"Using no way as way -
Having no limitation as limitation"

bb - It may be time to change your handle
["DNAP down she goes. hard to gap these daggon BBs. I dont trust them."]

Maybe this:
I_like_don't_trust_bb_stocks

"Using no way as way -
Having no limitation as limitation"

The proverbial falling knife..UAL.
It's going to get really ugly, IMO.

"Using no way as way -
Having no limitation as limitation"

Not recommending it now...
But what's up with ELANW?? +333%??

"Using no way as way -
Having no limitation as limitation"

Nice find, art! Thanks!!!eom

"Using no way as way -
Having no limitation as limitation"

CORV - making its move!
Looking good for this week!

"Using no way as way -
Having no limitation as limitation"

UAL - I got in on the news this morning, Patsy.
I've set a target of 3.40. It'll probably go higher than that, but I've had luck recently hopping in and getting 10-20 percent returns.

"Using no way as way -
Having no limitation as limitation"

Whip - you're welcome (CORV)
Next week should be really fun. I have an idea that the market is going to be great! Let's make a million before the year's end, what do you say?

"Using no way as way -
Having no limitation as limitation"

Whip, looks like CORV is trying to break out!
Island is showing .90/.91 now

"Using no way as way -
Having no limitation as limitation"

Anybody else in CORV?
I jumped in when I saw the ticker on CNBC. In at .80 now .87
I don't know what's up. But all buys.....

"Using no way as way -
Having no limitation as limitation"

XOXOQ - a warning:
It looks like if you got XOXOQ after 11/15 (and you're still holding - I'm not) you will not be included in the distribution of the new stock. In other words, it would be worthless.

["PERSONS WHO ACQUIRE CLAIMS OR INTERESTS IN XO AFTER NOVEMBER 15, 2002 ARE NOT

ENTITLED TO ANY DISTRIBUTIONS UNDER THE PLAN AND ARE NOT ENTITLED TO PARTICPATE

IN THE RIGHTS OFFERING."]



"Using no way as way -
Having no limitation as limitation"

BB - how many stocks ran for miles the minute that you called them a POS? I think that the term is "contrarian indicator"! LOL!!!

"Using no way as way -
Having no limitation as limitation"

Thanks RCT2!
I picked some up at .02

"Using no way as way -
Having no limitation as limitation"

BB about xoxoq:
Still in with my acct. though I took most off the table at .17 . Took all the profits on the wifie's account. Not taking any chances there!!

"Using no way as way -
Having no limitation as limitation"

Out of IBCL @ .038!
This has been a great day! How about for you all?

"Using no way as way -
Having no limitation as limitation"

In another bb stock IBCL
@.028 starting to move.

"Using no way as way -
Having no limitation as limitation"

xoxoq - round 2
Got 10K for wifie's account @ .122

"Using no way as way -
Having no limitation as limitation"

The good news is about xoxoq -
That it has only moderate volume so far (8 mill) There's lots more upside, IMO.

"Using no way as way -
Having no limitation as limitation"

I picked it up, RCT2!
Got in at 11.5 cents! Holding for a big payoff here!

"Using no way as way -
Having no limitation as limitation"

Probably, BB....
But as you can see from the fact that it's up almost 100% alreaday -- some traders (including me) are letting it run!!!

"Using no way as way -
Having no limitation as limitation"

xoxoq running for real!
News includes common shareholders.

"Using no way as way -
Having no limitation as limitation"

xoxoq running! eom

"Using no way as way -
Having no limitation as limitation"

IDNW a P/E of 4.10?
Sounds too good, but so does a profitable company trading at 4 cents......

"Using no way as way -
Having no limitation as limitation"

XOXOQ:
"common shareholders will get some of that new equity"

"Using no way as way -
Having no limitation as limitation"

Much movement on XOXOQ eom

"Using no way as way -
Having no limitation as limitation"

I agree with you, arabianfrancine about IDNW.
A drop of 50% on profit-taking on good news should imply a rebound on Monday. I even bought a little bit when it bottomed on Friday. It looked like a gift to me. I like gifts!

"Using no way as way -
Having no limitation as limitation"

IDNW .043/.045
Interesting development, considering the news....I may jump in! Yeah, me! In an OTCBB...WTH......


"Using no way as way -
Having no limitation as limitation"

DFNS news just out
http://biz.yahoo.com/bw/021115/150104_1.html

"Using no way as way -
Having no limitation as limitation"

IRAQ capitulates.
Should be a positive for the markets.

"Using no way as way -
Having no limitation as limitation"

Bought ftgx @.15
Lots of interest. Keep an eye on it!

"Using no way as way -
Having no limitation as limitation"